University Health Network-Princess Margaret Cancer Center

Toronto, Ontario MISG 2M9

1 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Cutaneous Squamous Cell Carcinoma, FGF19 Gene Amplification, FGF19 Gene Overexpression, FGFR Gene Alterations, FGFR Gene Amplification, FGFR3 Gene Alteration, FGFR3 Gene Fusions, FGFR3 Gene Mutation, FGFR4 Gene Fusions, FGFR4 Gene Mutation, Locally Advanced Unresectable Hepatocellular Carcinoma

Studies at this site

• Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations — Recruiting now
• A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma — Recruiting now
• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
• ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3) — Running, not enrolling
• Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma — Completed